Shares of HIMS experienced a dramatic slump today following the unexpected termination of its partnership with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending the company's stock price plummeting by more than 20%. The reason for the breakdown of the partnership remains unclear, but industry analysts speculat